Summary
Evidence is presented that 5-HT3 receptor antagonists such as ondansetron are highly effective in influencing behavioural disturbance in the absence of effect on normal behaviour. The 5-HT3 receptor antagonists demonstrate a remarkable potency and breadth of action over a wide dose range in rodent and primates to inhibit aversive behaviour, antagonise the hyperactivity caused by mesolimbic dopamine excess and facilitate performance in cognitive tests. These effects are achieved in the absence of withdrawal phenomana following cessation of chronic treatment. The studies indicate a widespread role for 5-HT3 receptors in the regulation of mesolimbic-cortical functioning, and the importance of the 5-HT3 receptor antagonists as investigative tools to establish the role of 5-HT3 receptors in anxiety, schizophrenia and cognitive dysfunction, and their treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ashby, C. R., Edwards, F., Harkins, K., and Wang, R. Y. (1989). Characterisation of 5-hydroxytryptamine3 receptors in the medial prefrontal cortex: a microiontopholetic study. Eur. J. Pharmacol. 173: 193–196.
Barnes, J. M., Barnes, N. M., Costall, B., Naylor, R. J., and Tyers, M. B. (1989). 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 338: 762–763.
Barnes, J. M., Costall, B., Coughlan, J., Domeney, A. M., Gerrard, P. A., Kelly, M. E., Naylor, R. J., Onaivi, E. S., Tomkins, D. M., and Tyers, M. B. (1990). The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates. Pharmacol. Biochem. Behay. 35: 955–962.
Barnes, N. M., Costall, B., Ironside, J. W., and Naylor, R. J. (19886). Identification of 5-HT3 recognition sites in human brain using 3H.zacopride. J. Pharmac. Pharmacol. 40: 668.
Barnes, N. M., Costal!, B., and Naylor, R. J. (1988a). 3H.zacopride: a ligand for the identification of 5-HT3 recognition sites. J. Pharm. Pharmacol. 40: 548–551.
Bartus, R. T., Dean, R. L., Beer, B., and Lippa, A. S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417.
Bradley, P. B., Engel, G., Feniuk, G., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., and Saxena, P. R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacol. 25: 563–576.
Carboni, E., Acquas, E., Frau, R., and DiChiara, G. (1989a). Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. Eur. J. Pharmacol. 164: 515–519.
Carboni, E., Acquas, E., Leone, P., and DiChiara, G. (1989b). 5-HT3 receptor antagonists block morphine-and nicotine-but not amphetamine-induced reward. Psychopharmacology 97: 175–178.
Costall, B., Domeney, A. M., Jones, B. N. C., and Naylor, R. J. (1988a). Assessment of behavioural parameters associated with anxiogenesis in the common marmoset (Callithrix jacchus). Br. J. Pharmacol. 95: 670P.
Costall, B., Domeney, A. M., Naylor, R. J., and Tyers, M. B. (1987). Effects on the 5-HT3 receptor antagonist GR 38032F on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br. J. Pharmacol. 92: 881–894.
Costall, B., Jones, B. J., Kelly, M. E., Naylor, R. J., Oakley, N. R., Onaivi, E. S., and Tyers, M. B. (1989). The effects of ondanestron (GR 38032F) in rats and mice treated subchronically with diazepam. Pharmacol. Biochem. Behay. 34: 769–778.
Costall, B., Jones, B. J., Kelly, M. E., Naylor, R. J., Onaivi, E. S., and Tyers, M. B. (1990a). Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol. Biochem. Behay. 36: 97–104.
Costall, B., Kelly, M. E., Naylor, R. J., Onaivi, E. S., and Tyers, M. B. (1988b). Neuroanatomical sites of action of 5-HT3 receptor antagonists to alter exploratory behaviour of the mouse. Br. J. Pharmacol. 96: 325–332.
Costall, B., and Naylor, R. J. (1990). 5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders. Scand. J. Gastroenterol. 25: 769–787.
Costall, B., Naylor, R. J., and Tyers, M. B. (1990b). The psychopharmacology of 5-HT3 receptors. Pharmac. Ther. 47: 181–202.
Cutler, M. G., and Dixon, A. K. (1989). Effects of the 5-HT3 antagonist, ICS 205–930, on behaviour of mice during social encounters. Br. J. Pharmacol. 96: 12P.
Cutler, M. G., and Dixon, A. K. (1989). Effects of the 5-HT3 antagonist, ICS 205–930, on behaviour of mice during social encounters. Br. J. Pharmacol. 96: 12P.
Essman, W. B. (1978). Serotonin in learning and memory. In: Essman, W. B. (ed.) Serotonin in health and disease. Vol. III. The central nervous system. New York, Spectrum Publications, pp. 69–143.
File, S. E. (1980). The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Meth. 2: 219–238.
File, S. E., and Johnston, A. L. (1989). Lack of effects of 5-HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology 99: 248–251.
Fozard, J. R. (1984). MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg’s Arch. Pharmacol. 326: 3644.
Grupp, L. A., Perlanski, E., and Stewart, R. B. (1988). Attenuation of alcohol intake by a serotonin uptake inhibitor: Evidence for mediation through the renin-angiotensin system. Pharmacol. Biochem. Behay. 30: 823–827.
Hagan, R. M., Butler, A., Hill, J. M., Jordan, C. C., Ireland, S. J., and Tyers, M. B. (1987). Effect of the 5-HT3 receptor antagonist, GR 38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain. Eur. J. Pharmacol. 138: 303–305.
Hagan, R. M., Jones, B. J., Jordan, C. C., and Tyers, M. B. (1990). Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat. Br. J. Pharmacol. 99: 227–232.
Higgins, G. A., Jones, B. J., Oakley, N. R., and Tyers, M. B. (1989). Evidence that the amygdala and not area postrema is involved in the putative anxiolytic effects of 5-HT3 receptor antagonists. Br. J. Pharmacol. 98: 635P.
Ireland, S. J., and Tyers, M. B. (1987). Pharmacological characterisation of 5-hydroxytryptamine-induced depolarisation of the rat isolated vagus nerve. Br. J. Pharmacol. 90: 229–238.
Johnston, A. L., and File, S. E. (1988). Effects of 5-HT3 antagonists in two animal tests of anxiety. Neurosci. Lett. 32: S44.
Jones, B. J., Costall, B., Domeney, A. M., Kelly, M. E., Naylor, R. J., Oakley, N. R., and Tyers, M. B. (1988). The potential anxiolytic activity of GR 38032F, a 5-HT3 receptor antagonist. Br. J. Pharmacol. 93: 985–993.
Kilfoil, T., Michael, A., Montgomery, D., and Whiting, R. L. (1989). Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice. Neuropharmacology 28: 901–905.
Kilpatrick, G. J., Jones, B. J., and Tyers, M. B. (1987). Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330: 746–748.
Morinan, A. (1989). Effects of the 5-HT3 receptor antagonists, GR 38032F and BRL 24924 on anxiety in socially isolated rats. Br. J. Pharmacol. 97: 457P.
Oakley, N. R., Jones, B. J., Tyers, M. B., Costall, B., and Domeney, A. M. (1988). The effect of ondansetron on alcohol consumption in the marmoset. Br. J. Pharmacol. 95: 870P.
Onaivi, E. S., and Martin, B. R. (1989). Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white test box for the assessment of anxiety. Prog. Neuropsychopharmacol. Biol. Psychiat. 13: 963–976.
Papp, M., and Przegalinski, E. (1989). The 5-HT3 receptor antagonists ICS 205–930 and GR 38032F, putative anxiolytic drugs, differ from diazepam in their pharmacological profile. J. Psychopharmacol. 3: 14–20.
Piper, D., Upton, N., Thomas, D., and Nicholson, J. (1988). The effects of the 5-HT3 receptor antagonists BRL 43694 and GR 38032F in animal behavioural models of anxiety. Br. J. Pharmacol. 94: 314P.
Richardson, B. P., Engel, S., Donatsch, P., and Stadler, P. A. (1985). Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316: 125–131.
Sellers, E. M., Kaplan, H. L., Lawrin, M. O., Somer, G., Noranjo, C. A., and Frecker, R. C. (1988). The 5-HT3 antagonist GR 38032F decreases alcohol consumption in rats. Soc. Neurosci. 18th An. Meet. Toronto Abstr. 21. 4.
Sorensen, S. M., Humphreys, T. M., and Palfreyman, M. G. (1989). Effect of acute and chronic MDL 73, 147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurones. Eur. J. Pharmacol. 163: 115–118.
Vogel, J. R., Beer, B., and Clody, D. E. (1971). A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacology 21: 1–7.
Young, R., and Johnson, D. N. (1988). Comparative effects of zacopride, GR 38032F, buspirone and diazepam in the mouse light/dark exploratory model. Soc. Neurosci. Abst. 14: 207.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Costall, B., Naylor, R.J. (1991). Influence of 5-HT3 Receptor Antagonists on Limbic-Cortical Circuitry. In: Fozard, J.R., Saxena, P.R. (eds) Serotonin: Molecular Biology, Receptors and Functional Effects. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7259-1_43
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7259-1_43
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7261-4
Online ISBN: 978-3-0348-7259-1
eBook Packages: Springer Book Archive